FDA Inspection 1164036 — Vilnis Lietuvietis
The FDA completed an inspection of Vilnis Lietuvietis on Feb 18, 2022 in Riga. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 18, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Riga (Latvia)
Additional Details
Clinical Investigator (CI)